ELRIG
Drug Discovery 2015
Wednesday, 2 Sep 2015 to Thursday, 3 Sep 2015
Drug Discovery 2015
Overview
General Info
Speakers
Presentations
Programme
Posters
Exhibitors
Delegates
Forum
Filter:

Invited Speakers

Barnard
Speaker
Alun Barnard
Senior Postdoctoral Researcher
Oxford University
Benson
Speaker
Neil Benson
Director
Xenologiq
Bickle
Speaker
Dr Marc Bickle
Head of Technology Development Studio
Max Planck Institute of Molecular Cell Biology and Genetics
Biffi
Speaker
Alessandra Biffi
Head of Unit
TIGET, IRCCS San Raffaele Scientific Institute
Bountra
Speaker
Prof Chas Bountra
Chief Scientist
SGC, University of Oxford
Bremberg
Speaker
Ulf Bremberg
Chief Scientific Officer
Beactica
Broccoli
Speaker
Vania Broccoli
Senior Scientist
Italian Research Council (CNR) and Ospedale San Raffaele
Carpenter
Speaker
Dr Anne Carpenter
Imaging Platform Director
Broad Institute of Harvard and MIT
LinkedIn
Chapman
Speaker
Katie Chapman
Senior Assay Development Scientist
Domainex
Charlton
Speaker
Steven Charlton
Professor of Molecular Pharmacology and Drug Discovery
University of Nottingham
Chien
Speaker
Ken Chien
Distinguished Professor of Swedish Research Council
Karolinska Instituet
Conde
Speaker
Miguel Conde
Scientist, Lead Characterisation
Ablynx
Crabbe
Speaker
Tom Crabbe
Director, External Discovery Solutions
UCB
Dietz
Speaker
Christian Dietz
PhD Student / Research Assistant
University of Konstanz
Dillon
Speaker
Christian Dillon
Senior Group Leader
Cancer Research Technology Discovery Laboratory
DiMaggio
Speaker
Pete DiMaggio
Lecturer
Imperial College London
Edwards
Speaker
Michael Edwards
CSO/ Senior Lecturer in Respiratory Medicine & Infections
Imperial College London
Fish
Speaker
Paul Fish
Professor and Chair of Medicinal Chemistry
UCL School of Pharmacy
Foldes
Speaker
Gabor Foldes
Associate Professor
National Heart and Lung Institute, Imperial College London
Gilham
Speaker
Dr David Gilham
Senior Research Fellow
Manchester University
Girach
Speaker
Aniz Girach
Chief Medical Officer
NightstaRx
Goldberg
Speaker
Dr Frederick Goldberg
Senior Medicinal Chemist
AstraZeneca
Grimley
Speaker
Rachel Grimley
Director Screening Sciences UK&US
AstraZeneca
Gritti
Speaker
Angela Gritti
Group Leader, TIGET Unit
San Raffaele Telethon Institute for Gene Therapy (TIGET)
Hartley
Speaker
John Hartley
Professor of Cancer Studies
University College London
Heinis
Speaker
Christian Heinis
Assistant Professor
Ecole Polytechnique Fédérale de Lausanne (EPFL)
Hill
Speaker
Steve Hill
Professor
University of Nottingham
Holder
Speaker
Julie Holder
Head of iPSC Innovation
Roslin Cells
Holdgate
Speaker
Geoff Holdgate
AstraZeneca
Holliger
Speaker
Philipp Holliger
Program Leader
MRC Laboratory of Molecular Biology
Horvath
Speaker
Peter Horvath
Research Group Leader, Finland Distinguished Processor Fellow
Biological Research Centre of the Hungarian Academy of Sciences
Huber
Speaker
Tobias Huber
Professor of Medicine
University of Freiburg
Hübner
Speaker
Norbert Hübner
Professor and Chair in Cardiovascular and Metabolic Sciences
Max-Delbrück-Center for Molecular Medicine (MDC)
Hussell
Speaker
Prof Tracy Hussell
Director and Professor of Immunology
Manchester Collaborative Centre for Inflammation Research
Jakobsen
Speaker
Bent Jakobsen
Scientific Co-Founder
Adaptimmune
Jermutus
Speaker
Dr Lutz Jermutus
Senior Director, R&D Product Development Team Leader, Cardiovascular & Metabolic Diseases iMED
MedImmune
Karlsson
Speaker
Mattias Karlsson
Vice President of Business Development
Cellectricon AB
Kelly
Speaker
Daniel P. Kelly
Tavistock Distinguished Professor and Scientific Director
Sanford Burnham Prebys Medical Discovery Institute
Kelly
Speaker
Kim Kelly
Associate Professor of Biomedical Engineering
University of Virginia
Kettleborough
Speaker
Katy Kettleborough
Associate Director, Biology
MRC Technology
Kumar
Speaker
Sanj Kumar
Chairman
ELRIG
Littler
Speaker
Eddy Littler
Domainex
Lord
Speaker
Chris Lord
Team Leader and Reader in Cancer Genomics and Therapeutics
Institute of Cancer Research
Ludbrook
Speaker
Steve Ludbrook
Group Leader
GlaxoSmithKline
Martin Plaza
Speaker
Julio Martin Plaza
GlaxoSmithKline, Tres Cantos, Spain
McKerrecher
Speaker
Dr Darren McKerrecher
Associate Director Oncology Medicinal Chemistry
AstraZeneca
LinkedIn
McLaren
Speaker
Robert McLaren
Moore
Speaker
Jon Moore
CSO/ VP Oncology
Horizon Discovery
Murray
Speaker
James Murray
Director, Chemistry and Structural Sciences
Vernalis (R&D) Ltd
Newell
Speaker
Herbie Newell
Professor of Cancer Therapeutics
Newcastle University
Ottman
Speaker
Dr Christian Ottman
Associate Professor
Technical University Eindhoven
Phelan
Speaker
Anne Phelan
COO and Head of Pharmacology
Pfizer Neusentis
Pluchino
Speaker
Stefano Pluchino
University Lecturer and Honorary Consultant in Neurology
Wellcome Trust-MRC Stem Cell Institute, University of Cambridge (UK)
Powell
Speaker
Dr Ken Powell
Executive Chairman Reviral
Reviral
Price
Speaker
Leo Price
Chief Scientific Officer
OcellO
Rees
Speaker
Stephen Rees
Vice President Screening Sciences and Sample Management
AstraZeneca
Reinhard
Speaker
Friedrich Reinhard
Project Coordinator Science and Technology
Cellzome, a GSK company
Ryder
Speaker
Hamish Ryder
Director of Discovery
Cancer Research Technology
Schellenberger
Speaker
Volker Schellenberger
President and CEO
Amunix
Schindler
Speaker
Dr Marcus Schindler
Vice President, Head of CVMD iMed
AstraZeneca R&D Mölndal
Schneider
Speaker
Prof Michael Schneider
Head of Cardiovascular Science, National Heart and Lung Institute British Heart Foundation
Imperial College London
Schofield
Speaker
Christopher Schofield
Head of Organic Chemistry
Oxford University
Schopfer
Speaker
Uli Schopfer
Novartis
Simpson
Speaker
Peter Simpson
Director
N8 Research Partnership
Solari
Speaker
Roberto Solari
Visiting Professor, Imperial College
GlaxoSmithKline
Teufel
Speaker
Dan Teufel
Head of Chemistry
Bicycle Therapeutics
Thomas
Speaker
David Thomas
CEO
Traffick Therapeutiques, Inc
Thompson
Speaker
Neil Thompson
Senior Vice President Biology
Astex Pharmaceuticals
Torrance
Speaker
Chris Torrance
Chief Executive Officer
PhoreMost Ltd
Trezise
Speaker
Derek Trezise
Director and European Site Head
Essen Bioscience
Waring
Speaker
Dr Mike Waring
Principal Scientist
AstraZeneca
Webborn
Speaker
Peter Webborn
DSM Director Pharmacokinetics and MS Imaging
AstraZeneca R&D
Winpenny
Speaker
David Winpenny
Principal Scientist
Pfizer Neusentis
Wyatt
Speaker
Paul Wyatt
Head of Drug Discovery Unit
University of Dundee
Young
Speaker
Damian Young
Assistant Director, Center for Drug Discovery
Baylor College of Medicine

Speakers

Abdin
Delegate
Speaker
Mr Mohammed Abdin
Internal Sales Engineer
Hamamatsu Photonics UK Limited
Davies
Poster Presenter
Speaker
Dr Gareth Davies
AstraZeneca
Pires
Poster Presenter
Speaker
Dr Ana Pires
Scientist
Mission Therapeutics

Drug Discovery 2015